Table 2. Refractive outcomes after the implantation of phakic refractive lens reported by different authors.
Authors | n (eyes) | Mean preop SE (D) | Follow-up (months) | Mean postop SE (D) | % Eyes within ±1 D | Efficacy index | Safety index |
---|---|---|---|---|---|---|---|
Hoyos et al42 | 17 | −18.46 | 12 | −0.22±0.87 | 82 | ||
Hoyos et al42 | 14 | +7.77 | 12 | −0.38±0.82 | 79 | ||
Pallikaris et al38 | 34 | −14.70±2.65 | 17.17 ±3.76 | 0.61±0.89 | 79 | ||
Koivula et al30, 33 | 14 | −9.19 | 12 | −0.31±0.51 | |||
Koivula et al30,33 | 6 | +6.13 | 12 | −0.60±0.63 | |||
Koivula and Zetterström45 | 40 | +5.90±2.51 | 12 | −0.46±0.48 | 100 | 0.70 | 0.89 |
Jongsareejit32 | 50 | −12.54±4.22 (sph) −1.38±1.24 (cyl) | 12 | −0.23±0.38 | |||
Donoso et al26 | 53 | −17.27±4.58 | 8.0±9.4 | −0.23±1.05 | 71.2 | 1.0 | 1.40 |
Verde et al31 | 91 | −11.9±5.0 | 12 | 80 | 0.98 | 1.22 | |
Gil Cazorla et al29 | 16 | +5.65±1.41 | 12 | 0.07±0.43 | 100 | 0.9 | 0.8 |
Portaliu et al46 | 34 | −14.08±4.00 | 72 | −0.45±0.62 | 91.2 | ||
Pérez-Cambrodí et al51 | 35 | −10.25±3.19 | 57.34 ±9.24 | −0.11±0.36 | 97.14 | 1.16 | 1.26 |